Bioverativ Inc. 4 SEC Filings

Filed On	Filing
08 Mar 2018	Form 4: Protopapas Anna, Director Returned 1,056 shares to the issuer · Disposed of 5,455 Restricted Stock Units (Disposition to Issuer) · Disposed of 23,006 Non-Qualified Stock Option (Disposition to Issuer)
08 Mar 2018	Form 4: Posner Brian S, Director Returned 6,693 shares to the issuer · Disposed of 6,364 Restricted Stock Units (Disposition to Issuer) · Disposed of 29,798 Non-Qualified Stock Option (Disposition to Issuer)
08 Mar 2018	Form 4: Paglia Louis J, Director Gave 2,000 shares as a gift · Returned 3,056 shares to the issuer · Disposed of 5,455 Restricted Stock Units (Disposition to Issuer) · 1 more
08 Mar 2018	Form 4: Harris Timothy J.r., EVP, R & D Returned 838.9492 shares to the issuer · Disposed of 52,180 Restricted Stock Units (Disposition to Issuer) · Disposed of 68,315 Non-Qualified Stock Option (Disposition to Issuer)
08 Mar 2018	Form 4: Greene John, EVP, CFO and Treasurer Returned 5,951.011 shares to the issuer · Disposed of 56,957 Restricted Stock Units (Disposition to Issuer) · Disposed of 169,845 Non-Qualified Stock Option (Disposition to Issuer)
08 Mar 2018	Form 4: Germano Geno J, Director Disposed of 5,455 Restricted Stock Units (Disposition to Issuer) · Disposed of 21,729 Non-Qualified Stock Option (Disposition to Issuer)
08 Mar 2018	Form 4: Duvall Diantha, Chief Accounting Officer Returned 2,791 shares to the issuer · Disposed of 10,053 Restricted Stock Units (Disposition to Issuer) · Disposed of 18,092 Non-Qualified Stock Option (Disposition to Issuer)
08 Mar 2018	Form 4: DiFabio Andrea, EVP, Chief Legal Officer Returned 30,600.2032 shares to the issuer · Disposed of 39,307 Restricted Stock Units (Disposition to Issuer) · Disposed of 119,189 Non-Qualified Stock Option (Disposition to Issuer)
08 Mar 2018	Form 4: Denner Alexander J, Director Returned 1,170,001 shares to the issuer · Disposed of 5,455 Restricted Stock Units (Disposition to Issuer) · Disposed of 26,818 Non-Qualified Stock Option (Disposition to Issuer)
08 Mar 2018	Form 4: Cox John, Director Returned 185,094 shares to the issuer · Disposed of 185,042 Restricted Stock Units (Disposition to Issuer) · Disposed of 629,279 Non-Qualified Stock Option (Disposition to Issuer)
08 Mar 2018	Form 4: Vivaldi Coelho Rogerio, EVP, Chief Global Therapeutics Returned 5,758.0405 shares to the issuer · Disposed of 56,957 Restricted Stock Units (Disposition to Issuer) · Disposed of 169,845 Non-Qualified Stock Option (Disposition to Issuer)
08 Mar 2018	Form 4: Celona Lucia, EVP, HR & Corp Commun. Officer Returned 20,396.2462 shares to the issuer · Disposed of 39,307 Restricted Stock Units (Disposition to Issuer) · Disposed of 104,291 Non-Qualified Stock Option (Disposition to Issuer)
08 Mar 2018	Form 4: Brudnick Richard, EVP, Business Development Returned 22,952 shares to the issuer · Disposed of 39,307 Restricted Stock Units (Disposition to Issuer) · Disposed of 104,291 Non-Qualified Stock Option (Disposition to Issuer)
05 Mar 2018	Form 4: Duvall Diantha, Chief Accounting Officer Gave up 105 shares to cover exercise price or tax ($11K)
26 Feb 2018	Form 4: Duvall Diantha, Chief Accounting Officer Gave up 168 shares to cover exercise price or tax ($17.5K)
26 Feb 2018	Form 4: Cox John, Director Gave up 13,973 shares to cover exercise price or tax ($1.46M) · Gave up 5,794 shares to cover exercise price or tax ($607K)
26 Feb 2018	Form 4: Celona Lucia, EVP, HR & Corp Commun. Officer Gave up 1,235 shares to cover exercise price or tax ($129K) · Gave up 389 shares to cover exercise price or tax ($40.7K)
26 Feb 2018	Form 4: DiFabio Andrea, EVP, Chief Legal Officer Gave up 2,011 shares to cover exercise price or tax ($210K) · Gave up 917 shares to cover exercise price or tax ($96K)
26 Feb 2018	Form 4: Brudnick Richard, EVP, Business Development Gave up 1,419 shares to cover exercise price or tax ($148K) · Gave up 924 shares to cover exercise price or tax ($96.8K)
15 Feb 2018	Form 4: Greene John, EVP, CFO and Treasurer Received 7,114 shares by exercise or conversion · Gave up 2,118 shares to cover exercise price or tax ($219K)

08 Mar 2018

Returned 1,056 shares to the issuer · Disposed of 5,455 Restricted Stock Units (Disposition to Issuer) · Disposed of 23,006 Non-Qualified Stock Option (Disposition to Issuer)

08 Mar 2018

Form 4: Posner Brian S, Director

Returned 6,693 shares to the issuer · Disposed of 6,364 Restricted Stock Units (Disposition to Issuer) · Disposed of 29,798 Non-Qualified Stock Option (Disposition to Issuer)

08 Mar 2018

Form 4: Paglia Louis J, Director

Gave 2,000 shares as a gift · Returned 3,056 shares to the issuer · Disposed of 5,455 Restricted Stock Units (Disposition to Issuer) · 1 more

08 Mar 2018

Form 4: Harris Timothy J.r., EVP, R & D

Returned 838.9492 shares to the issuer · Disposed of 52,180 Restricted Stock Units (Disposition to Issuer) · Disposed of 68,315 Non-Qualified Stock Option (Disposition to Issuer)

08 Mar 2018

Form 4: Greene John, EVP, CFO and Treasurer

Returned 5,951.011 shares to the issuer · Disposed of 56,957 Restricted Stock Units (Disposition to Issuer) · Disposed of 169,845 Non-Qualified Stock Option (Disposition to Issuer)

08 Mar 2018

Form 4: Germano Geno J, Director

Disposed of 5,455 Restricted Stock Units (Disposition to Issuer) · Disposed of 21,729 Non-Qualified Stock Option (Disposition to Issuer)

08 Mar 2018

Form 4: Duvall Diantha, Chief Accounting Officer

Returned 2,791 shares to the issuer · Disposed of 10,053 Restricted Stock Units (Disposition to Issuer) · Disposed of 18,092 Non-Qualified Stock Option (Disposition to Issuer)

08 Mar 2018

Form 4: DiFabio Andrea, EVP, Chief Legal Officer

Returned 30,600.2032 shares to the issuer · Disposed of 39,307 Restricted Stock Units (Disposition to Issuer) · Disposed of 119,189 Non-Qualified Stock Option (Disposition to Issuer)

08 Mar 2018

Form 4: Denner Alexander J, Director

Returned 1,170,001 shares to the issuer · Disposed of 5,455 Restricted Stock Units (Disposition to Issuer) · Disposed of 26,818 Non-Qualified Stock Option (Disposition to Issuer)

08 Mar 2018

Form 4: Cox John, Director

Returned 185,094 shares to the issuer · Disposed of 185,042 Restricted Stock Units (Disposition to Issuer) · Disposed of 629,279 Non-Qualified Stock Option (Disposition to Issuer)

08 Mar 2018

Form 4: Vivaldi Coelho Rogerio, EVP, Chief Global Therapeutics

Returned 5,758.0405 shares to the issuer · Disposed of 56,957 Restricted Stock Units (Disposition to Issuer) · Disposed of 169,845 Non-Qualified Stock Option (Disposition to Issuer)

08 Mar 2018

Form 4: Celona Lucia, EVP, HR & Corp Commun. Officer

Returned 20,396.2462 shares to the issuer · Disposed of 39,307 Restricted Stock Units (Disposition to Issuer) · Disposed of 104,291 Non-Qualified Stock Option (Disposition to Issuer)

08 Mar 2018

Form 4: Brudnick Richard, EVP, Business Development

Returned 22,952 shares to the issuer · Disposed of 39,307 Restricted Stock Units (Disposition to Issuer) · Disposed of 104,291 Non-Qualified Stock Option (Disposition to Issuer)

05 Mar 2018

Form 4: Duvall Diantha, Chief Accounting Officer

Gave up 105 shares to cover exercise price or tax ($11K)

26 Feb 2018

Form 4: Duvall Diantha, Chief Accounting Officer

Gave up 168 shares to cover exercise price or tax ($17.5K)

26 Feb 2018

Form 4: Cox John, Director

Gave up 13,973 shares to cover exercise price or tax ($1.46M) · Gave up 5,794 shares to cover exercise price or tax ($607K)

26 Feb 2018

Form 4: Celona Lucia, EVP, HR & Corp Commun. Officer

Gave up 1,235 shares to cover exercise price or tax ($129K) · Gave up 389 shares to cover exercise price or tax ($40.7K)

26 Feb 2018

Form 4: DiFabio Andrea, EVP, Chief Legal Officer

Gave up 2,011 shares to cover exercise price or tax ($210K) · Gave up 917 shares to cover exercise price or tax ($96K)

26 Feb 2018

Form 4: Brudnick Richard, EVP, Business Development

Gave up 1,419 shares to cover exercise price or tax ($148K) · Gave up 924 shares to cover exercise price or tax ($96.8K)

15 Feb 2018

Form 4: Greene John, EVP, CFO and Treasurer

Received 7,114 shares by exercise or conversion · Gave up 2,118 shares to cover exercise price or tax ($219K)